Inventor · disambiguated record
Parag Shah
Also filed as: SHAH PARAG · SHAH PARAG SURESH
10 granted patents·29 pending applications·141 citations·filing 2005–2023
90Inventor score
Files withBELLEROPHON THERAPEUTICS6MALLINCKRODT HOSPITAL PRODUCTS IP LTD6AUSPEX PHARMACEUTICALS INC5BELLEROPHON PULSE TECH LLC4MOFFETT ALEX4
Top patents by PatentIndex Score
39 records- 0195US10556082B2Cannula for minimizing dilution of dosing during nitric oxide deliveryMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2017·Granted Feb 11, 2020·21 cites·10 claims
- 0295US8770199B2Cannula for minimizing dilution of dosing during nitric oxide deliveryINO THERAPEUTICS LLC·Filed 2013·Granted Jul 8, 2014·50 cites·28 claims
- 0391US9795756B2Cannula for minimizing dilution of dosing during nitric oxide deliveryMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2013·Granted Oct 24, 2017·32 cites·21 claims
- 0491US9550039B2Cannula for minimizing dilution of dosing during nitric oxide deliveryMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2014·Granted Jan 24, 2017·24 cites·18 claims
- 0580US9032959B2Cannula for minimizing dilution of dosing during nitric oxide deliveryINO THERAPEUTICS LLC·Filed 2013·Granted May 19, 2015·7 cites·33 claims
- 0678US11311488B2Osmotic dosage forms comprising deutetrabenazine and methods of use thereofAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·1 cites·28 claims
- 0773US10918819B2Cannula for minimizing dilution of dosing during nitric oxide deliveryMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2017·Granted Feb 16, 2021·1 cites·20 claims
- 0873US8367864B2Dimeric double metal salts of (−)-hydroxycitric acid, methods of making and uses of sameGLYKON TECHNOLOGIES GROUP LLC·Filed 2010·Granted Feb 5, 2013·5 cites·7 claims
- 0971US11786687B2Cannula for minimizing dilution of dosing during nitric oxide deliveryMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2020·Granted Oct 17, 2023·0 cites·18 claims
- 1070US2010003331A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2009·Application pending·0 cites
- 1164US2021260327A1Cannula For Minimizing Dilution Of Dosing During Nitric Oxide DeliveryMallinckrodt Hospital Products IP Unlimited Company·Filed 2021·Application pending·0 cites
- 1262US2023022862A1Osmotic dosage forms comprising deutetrabenazine and methods of use thereofAUSPEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1358US2008305161A1Injectable depot formulations and methods for providing sustained release of nanoparticle compositionsPFIZER·Filed 2008·Application pending·0 cites
- 1456US10130783B2Cannula for minimizing dilution of dosing during nitric oxide deliveryMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2015·Granted Nov 20, 2018·0 cites·17 claims
- 1555US2020078354A1Immediate release abuse deterrent tabletALLERGAN SALES LLC·Filed 2019·Application pending·0 cites
- 1654US2025302869A1Use of inhaled nitric oxide (ino) for treating patients with pulmonary hypertension associated with sarcoidosis (ph-sarc)MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 1753US2023067942A1IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENTBELLEROPHON THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1852US2024374528A1Multiparticulate dosage forms comprising deutetrabenazineAUSPEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1950US2023158064A1USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19BELLEROPHON THERAPEUTICS·Filed 2021·Application pending·0 cites
- 2050US2020360647A1Use Of Inhaled Nitric Oxide For The Improvement Of Right And/Or Left Ventricular FunctionBELLEROPHON PULSE TECH LLC·Filed 2018·Application pending·0 cites
- 2150US2020188319A1Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung DiseaseBELLEROPHON PULSE TECH LLC·Filed 2018·Application pending·0 cites
- 2249US2017304297A1Immediate release abuse deterrent tabletALLERGAN SALES LLC·Filed 2017·Application pending·0 cites
- 2348US2023364075A1Multiparticulate dosage forms comprising deutetrabenazineAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2447US2022079883A1Eltrombopag choline dosage formsACTAVIS LABORATORIES FL INC·Filed 2021·Application pending·0 cites
- 2547US2023390192A1Gastro retentive dosage forms comprising deutetrabenazineAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2647US2008145408A1Dimeric Double Metal Salts of (-) Hydroxycitric Acid, Methods of Making and Uses of SameMOFFETT ALEX·Filed 2006·Application pending·0 cites
- 2746US2023158260A1Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemiaBELLEROPHON THERAPEUTICS·Filed 2019·Application pending·0 cites
- 2846US2013150448A1Dimeric double metal salts of (-) hydroxycitric acid, methods of making and uses of sameGLYKON TECHNOLOGIES GROUP LLC·Filed 2013·Application pending·0 cites
- 2946US2015224097A1Immediate Release Abuse Deterrent TabletSAREEN RAHUL·Filed 2011·Application pending·0 cites
- 3044US2020360425A1Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary HypertensionBELLEROPHON PULSE TECH LLC·Filed 2018·Application pending·0 cites
- 3144US2021220586A1Method and apparatus for pulsatile delivery of nitric oxideBELLEROPHON THERAPEUTICS·Filed 2019·Application pending·0 cites
- 3244US2020384014A1Pulsed Administration Of Inhaled Nitric Oxide For The Treatment Of Pulmonary HypertensionBELLEROPHON PULSE TECH LLC·Filed 2018·Application pending·0 cites
- 3343US2012022017A1Composition and a method thereofPATELL VILLOO MORAWALA·Filed 2009·Application pending·0 cites
- 3442US2006292255A1Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plantMOFFETT ALEX·Filed 2006·Application pending·0 cites
- 3542US2008193542A1Injectable Deopot Formulations and Methods For Providing Sustained Release of Nanoparticle CompositionsPFIZER·Filed 2006·Application pending·0 cites
- 3641US2006105069A1Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plantMOFFETT ALEX·Filed 2005·Application pending·0 cites
- 3738US2022080147A1USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONSBELLEROPHON THERAPEUTICS·Filed 2020·Application pending·0 cites
- 3836US2022096535A1Combination drug therapies of pde-5 inhibitors and inhaled nitric oxideBELLEROPHON THERAPEUTICS·Filed 2020·Application pending·0 cites
- 3933US2006198907A1Pharmaceutical, therapeutic, and dietary compositions derived from Lagerstroemia speciosa L. plantMOFFETT ALEX·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Parag Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →